The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLitigation Cap. Regulatory News (LIT)

Share Price Information for Litigation Cap. (LIT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 120.00
Bid: 119.00
Ask: 120.00
Change: -0.75 (-0.62%)
Spread: 1.00 (0.84%)
Open: 121.00
High: 121.00
Low: 119.00
Prev. Close: 120.75
LIT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Funding of Corporate Portfolio Transaction

24 Aug 2020 07:00

RNS Number : 9369W
Litigation Capital Management Ltd
24 August 2020
 

24 August 2020

 

Litigation Capital Management Limited

("LCM" or the "Company")

 

Funding of Corporate Portfolio Transaction

 

 

Litigation Capital Management Limited (AIM:LIT), a specialist alternate asset manager and leading international disputes financing solutions provider, announces it has executed a portfolio finance agreement to provide a significant finance facility to a subsidiary of a global building and infrastructure contractor to fund a portfolio of its construction claims.

 

This large corporate portfolio transaction involves an agreement to fund up to 20 separate claims (subject to the satisfactory completion by LCM of its due diligence) seated in territories ranging from Dubai to London.

 

The transaction was originated through LCM's strategic alliance with Norton Rose Fulbright and has involved members of LCM's team from Sydney, London and a specialist team established in the UAE.

 

LCM is the only participant in the disputes finance market originating and executing corporate portfolio transactions of this magnitude, demonstrating its ability to create innovative and bespoke legal financing solutions that truly meet the needs of the corporate.

 

As announced on 10 July 2020, LCM achieved four resolutions in both its building and construction portfolio and its aviation portfolio during the financial year ended 30 June 2020, with this investment strategy of providing disputes finance on a portfolio basis continuing to deliver strong metrics for LCM.

 

Patrick Moloney, Chief Executive Officer of LCM, comments: "We are delighted to be announcing a further corporate portfolio transaction which originated as the result of our important relationship with Norton Rose Fulbright. LCM has the most experienced team in the market for originating and executing such transactions which, as an investment strategy, has proven to achieve strong and consistent returns within a shorter timeframe compared with traditional single-case investments."

Nick Rowles-Davies, Executive Vice Chairman of LCM, added: "Transactions of this calibre are not being achieved by any of LCM's competition. This corporate portfolio further cements our position as leading the global market in corporate portfolio transactions and comes at a time of considerable growth and increased opportunity for LCM."

Cameron Harvey, Head of Disputes of Norton Rose Fulbright, comments: "LCM's finance facility will be of great benefit to our client and its ability to manage legal claims across multiple jurisdictions. Norton Rose Fulbright entered into a strategic alliance with LCM because we foresaw a growing need for corporate litigants to be able to engage in necessary dispute resolution without having the experience cripple their balance sheets, something which is even more crucial during the COVID-19 pandemic. We look forward to continuing to work with LCM to offer financing and legal solutions to our international and domestic clients as they adjust to the impact of the pandemic and emerge during the eventual recovery."

 

 

Enquiries

 

Litigation Capital Management

c/o Alma PR 

Patrick Moloney, Chief Executive Officer

Canaccord (Nomad and Joint Broker) 

Tel: 020 7523 8000

Bobbie Hilliam

Investec Bank plc (Joint Broker)

Tel: 020 7597 5970

David Anderson

Alma PR

Tel: 020 3405 0205

Justine James

Rebecca Sanders-Hewett

LCM@almapr.co.uk

Susie Hudson

 

 

NOTES TO EDITORS

 

Litigation Capital Management (LCM) is a specialist alternate asset manager and leading international disputes financing solutions provider which operates two business models. The first is direct investments made from LCM's permanent balance sheet capital and the second is fund and/or asset management. Under those two business models, LCM currently pursues three investment strategies: Single-case funding, Corporate portfolio funding and Acquisitions of claims. LCM generates its revenue from both its direct investments and also performance fees through asset management.

 

LCM has an unparalleled track record driven by disciplined project selection and robust risk management.

 

Currently headquartered in Sydney, with offices in London, Singapore, Brisbane and Melbourne, LCM listed on AIM in December 2018, trading under the ticker LIT.

 

www.lcmfinance.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCKKQBBQBKKKFB
Date   Source Headline
10th May 20247:00 amRNSTransaction in Own Shares
9th May 20247:00 amRNSTransaction in Own Shares
7th May 20247:00 amRNSTransaction in Own Shares
3rd May 20247:00 amRNSTransaction in Own Shares
2nd May 20247:00 amRNSTransaction in Own Shares
1st May 20247:00 amRNSTransaction in Own Shares
26th Apr 20247:00 amRNSTransaction in Own Shares
24th Apr 20247:00 amRNSTransaction in Own Shares
22nd Apr 20247:00 amRNSTransaction in Own Shares
18th Apr 20247:00 amRNSTransaction in Own Shares
17th Apr 20247:00 amRNSTransaction in Own Shares
16th Apr 20247:00 amRNSTransaction in Own Shares
12th Apr 20247:00 amRNSTransaction in Own Shares
11th Apr 20247:00 amRNSTransaction in Own Shares
10th Apr 20247:00 amRNSTransaction in Own Shares
9th Apr 20247:00 amRNSTransaction in Own Shares
8th Apr 20247:00 amRNSTransaction in Own Shares
5th Apr 20247:00 amRNSTransaction in Own Shares
3rd Apr 20247:00 amRNSTransaction in Own Shares
28th Mar 20247:00 amRNSTransaction in Own Shares
27th Mar 20247:00 amRNSTransaction in Own Shares
26th Mar 20247:00 amRNSTransaction in Own Shares
25th Mar 20247:00 amRNSTransaction in Own Shares
22nd Mar 20247:00 amRNSTransaction in Own Shares
21st Mar 20247:00 amRNSTransaction in Own Shares
20th Mar 20247:00 amRNSTransaction in Own Shares
19th Mar 20247:01 amRNSTransaction in Own Shares
19th Mar 20247:00 amRNSInterim results for the HY ended 31 December 2023
18th Mar 20247:00 amRNSTransaction in Own Shares
15th Mar 20247:00 amRNSTransaction in Own Shares
14th Mar 20247:00 amRNSTransaction in Own Shares
13th Mar 20247:00 amRNSTransaction in Own Shares
12th Mar 20247:00 amRNSTransaction in Own Shares
11th Mar 20247:00 amRNSTransaction in Own Shares
8th Mar 20247:00 amRNSTransaction in Own Shares
7th Mar 20247:00 amRNSTransaction in Own Shares
6th Mar 20247:00 amRNSTransaction in Own Shares
5th Mar 20247:00 amRNSTransaction in Own Shares
4th Mar 20247:00 amRNSTransaction in Own Shares
1st Mar 20247:00 amRNSTransaction in Own Shares
29th Feb 20247:00 amRNSTransaction in Own Shares
28th Feb 20247:00 amRNSTransaction in Own Shares
27th Feb 20247:00 amRNSTransaction in Own Shares
26th Feb 20247:00 amRNSTransaction in Own Shares
23rd Feb 20247:00 amRNSTransaction in Own Shares
22nd Feb 20247:00 amRNSTransaction in Own Shares
21st Feb 20247:00 amRNSTransaction in Own Shares
20th Feb 20247:00 amRNSTransaction in Own Shares
19th Feb 20247:00 amRNSTransaction in Own Shares
16th Feb 20247:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.